Genotype phenotype classification of hepatocellular adenoma

查看全文 作　　者：Paulette Bioulac-[1,2,3]Sage;Jean Frédéric [2,3,4]Blanc;Sandra [5]Rebouissou;Charles [6]Balabaud;Jessica Zucman-[5]Rossi

机构地区：[1]CHU Bordeaux, Hpital Pellegrin, Department of Pathology, Bordeaux F-33076, France;[2]Charles Balabaud, Inserm, U889, Bordeaux F-33076, GREF;[3]Univ Victor Segalen Bordeaux 2, Bordeaux F-33076, France;[4]Charles Balabaud, CHU Bordeaux, Hpital Saint André, Department of Hepatology, Bordeaux F-33075, France;[5]Inserm, U674, CEPH, Univ Paris 7, Paris F-75010, France;[6]CHU Bordeaux, Hpital Saint André, Department of Hepatology, Bordeaux F-33075, France

出　　处：《World Journal of Gastroenterology》索引2007年第13卷第19期,共6页

摘　　要：Studies that compare tumor genotype with phenotype have provided the basis of a new histological/molecular classification of hepatocellular adenomas. Based on two molecular criteria (presence of a TCF1/HNF1α or β-catenin mutation), and an additional histological criterion (presence or absence of an inflammatory infiltrate), subgroups of hepatocellular adenoma can be defined and distinguished from focal nodular hyperplasia. Analysis of 96 hepatocellular adenomas performed by a French collaborative network showed that they can be divided into four broad subgroups: the fi rst one is defi ned by the presence of mutations in TCF1 gene inactivating the hepatocyte nuclear factor 1 (HNF1α); the second by the presence of β-catenin activating mutations; the category without mutations of HNF1α or β-catenin is further divided into 2 subgroups depending on the presence or absence of in? ammation. Therefore, the approach to the diagnosis of problematic benign hepatocytic nodules may be entering a new era directed by new molecular information. It is hoped that immunohistological tools will improve significantly diagnosis of liver biopsy in our ability to distinguish hepatocellular adenoma from focal nodular hyperplasia (FNH), and to delineate clinically meaningful entities within each group to define the best clinical management. The optimal care of patients with a liver nodule will benefit from the recent knowledge coming from molecular biology and the combined expertise of hepatologists, pathologists, radiologists, and surgeons. 关键词：肝细胞腺瘤基因型表现型分类突变

相关文献

参考文献（23）
引证文献（9）
耦合文献（0）

参考文献(23)

引证文献(9)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Genotype phenotype classification of hepatocellular adenoma

参考文献(23)

引证文献(9)

用户提示